Company Profile

Frontline Biotechnologies Inc
Profile last edited on: 4/9/2023      CAGE: 8P6U9      UEI: XZAPQ4J49254

Business Identifier: Biological separation and purification technologies
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

1600 Broadway Street NE Suite 100
Minneapolis, MN 55413
   (651) 600-5627
Location: Single
Congr. District: 05
County: Ramsey

Public Profile

Structured around developing and commercializing biological separation and purification technologies for the biotech, diagnostics and pharmaceutical industries, Frontline’s current products offer a disruptive solution for environmental DNA (eDNA) collection, extraction and purification for bioconservation, aquaculture and wastewater-based epidemiology. Areas of expertise extend from Sample Collection: on-site sample collection technologies for rapid clinical and environmental diagnostics; Nucleic Acid Purification: enhanced extraction of nucleic acids from biological and environmental samples and for the RNA vaccine industry; to Antibody Purification: unification of antibodies and bacteriophages and development of the next generation of downstream processing technologies

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
Less than .5M
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Key People / Management

  Kyle King -- CEO

  Abdennour Abbas -- Founder and CTO

  Hamada Aboubakr

  Akli Zarouri -- Senior Engineer

Company News

There are no news available.